Evidence map›Paper›PMID 35335059›Full record

ReviewVaccines2022

COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis.

Muhammad Mainuddin Patwary, Md Ashraful Alam, Mondira Bardhan, Asma Safia Disha, Md Zahidul Haque, Sharif Mutasim Billah, Md Pervez Kabir, Matthew H E M Browning, Md Mizanur Rahman, Ali Davod Parsa and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 16 pooled it
22.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 16 syntheses or guidelines pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Article
  18. Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Muhammad Mainuddin PatwaryEnvironment and Sustainability Research Initiative, Khulna 9208, Bangladesh.ORCID 0000-0001-8895-9723
Md Ashraful AlamDepartment of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.ORCID 0000-0002-7562-477X
Mondira BardhanEnvironment and Sustainability Research Initiative, Khulna 9208, Bangladesh.ORCID 0000-0003-4642-1815
Asma Safia DishaEnvironment and Sustainability Research Initiative, Khulna 9208, Bangladesh.
Md Zahidul HaqueEnvironment and Sustainability Research Initiative, Khulna 9208, Bangladesh.
Sharif Mutasim BillahEnvironment and Sustainability Research Initiative, Khulna 9208, Bangladesh.ORCID 0000-0002-6923-023X
Md Pervez KabirEnvironment and Sustainability Research Initiative, Khulna 9208, Bangladesh.
Matthew H E M BrowningDepartment of Parks, Recreation and Tourism Management, Clemson University, Clemson, SC 29634, USA.ORCID 0000-0003-2296-7602
Md Mizanur RahmanHitotsubashi Institute for Advanced Study, Hitotsubashi University, 2-1 Naka Kunitachi, Tokyo 186-8601, Japan.
Ali Davod ParsaSchool of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Chelmsford CM1 1SQ, UK.ORCID 0000-0001-7390-4308
Russell KabirSchool of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Chelmsford CM1 1SQ, UK.ORCID 0000-0001-9257-2775
Khulna University · BDAnglia Ruskin University · GBClemson University · USHitotsubashi University · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Widespread vaccination against COVID-19 is critical for controlling the pandemic. Despite the development of safe and efficacious vaccinations, low-and lower-middle income countries (LMICs) continue to encounter barriers to care owing to inequitable access and vaccine apprehension. This study aimed to summarize the available data on COVID-19 vaccine acceptance rates and factors associated with acceptance in LMICs. A comprehensive search was performed in PubMed, Scopus, and Web of Science from inception through August 2021. Quality assessments of the included studies were carried out using the eight-item Joanna Briggs Institute Critical Appraisal tool for cross-sectional studies. We performed a meta-analysis to estimate pooled acceptance rates with 95% confidence intervals (CI). A total of 36 studies met the inclusion criteria and were included in the review. A total of 83,867 respondents from 33 countries were studied. Most of the studies were conducted in India (

Indexed as

COVID-19low- and lower-middle income countriesmeta-analysisSARS-CoV-2vaccinevaccine acceptancevaccine hesitancy

Identifiers

PMID35335059
PMCPMC8950670
OpenAlexW4220934491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.